GEN | News Highlights: Sanaria, IBBR Win $3M Grant for Malaria Vaccine Sporozoite Manufacture in Mosquitoes

Sanaria and the Institute for Bioscience and Biotechnology Research (IBBR) at the University of Maryland College Park won a $3 million, three-year phase 2 SBIR grant from NIAID to fund development of genetically engineered mosquitoes that produce parasites for Sanaria’s malaria vaccine manufacturing process. The new funds will enable continuation of the phase 1 SBIR grant-supported partnership between the organizations, which is leveraging the expertise of IBBR’s Insect Transformation Facility.

via GEN | News Highlights: Sanaria, IBBR Win $3M Grant for Malaria Vaccine Sporozoite Manufacture in Mosquitoes.

Advertisements


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s